Regencell Bioscience Holdings ratios data for the quarter ended Dec 2025. These financial ratios cover 7 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2020 | Jun2021 | Jun2022 | Jun2023 | Jun2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|
| Efficiency | |||||||
| Assets AverageAssets Avg. | 4.38M | ||||||
| Invested CapitalInvested Cap. | 0.42M | -0.32M | 17.11M | 12.00M | 8.23M | 4.86M | 1.22M |
| Leverage & Solvency | |||||||
| Debt Ratio | 5.97 | 0.00 | 0.00 | 0.00 | |||
| Valuation | |||||||
| Price to BookP/B | 0.69 | 0.66 | 0.14 | 45.62 | 224.11 | ||
| Enterprise Value | -4.55M | -3.72M | -6.81M | 216.84M | 270.91M | ||
| Market Capitalization | 11.85M | 7.89M | 1.15M | 221.74M | 273.27M |